PROFESSIONAL EDITION

The largest community of pharma leaders

BryoLogyx Names Omar Duramad, Ph.D., as Chief Scientific Officer

DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx appoints Omar Duramad, Ph.D. as Chief Scientific Officer to lead preclinical development of bryostatin and analogues…

 

 

http://www.businesswire.com/news/home/20190730005289/en/BryoLogyx-Names-Omar-Duramad-Ph.D.-Chief-Scientific 

Recent Articles